Pharmacologic Profile of Perphenazine's Metabolites
2000
The authors have previously reported that in elderly patients treated with low doses of perphenazine, few extrapyramidal symptoms (EPS) developed in those who were not poor CYP2D6 metabolizers. The authors hypothesized that this atypical side effect profile is due to perphenazine's principal metabol
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
24
References
25
Citations
NaN
KQI